Empyrean Capital Partners »

Vir Biotechnology shares owned by Empyrean Capital Partners

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Empyrean Capital Partners from 13F filings

Historical chart of Empyrean Capital Partners investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Empyrean Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Empyrean Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.7M 528k 8.96

More positions owned by Empyrean Capital Partners

Aercap Holdings Nv SHS (AER)
British Amern Tob Sponsored Adr (BTI)
Shell Spon Ads (SHEL)
Marathon Petroleum Corp (MPC)
Norfolk Southern (NSC)
Constellation Brands Cl A (STZ)
PNM Resources (TXNM)
Brightsphere Investment Group (AAMI)
Warner Bros Discovery Com Ser A (WBD)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Commscope Hldg (VISN)
Newmark Group Cl A (NMRK)
Union Pacific Corporation (UNP)
Axalta Coating Sys (AXTA)
Bristow Group (VTOL)

View all positions for Empyrean Capital Partners

Top funds holding Vir Biotechnology

BlackRock
Arch Venture Corp
Vanguard Group
Sb Investment Advisers
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
FMR
Morgan Stanley
ADAR1 Capital Management
Geode Capital Management
Dimensional Fund Advisors
Citadel Advisors
Soleus Capital Management

View all funds holding Vir Biotechnology